Aratana Therapeutics, Inc.
PETX
PETX was delisted on the 17th of July, 2019.
82 hedge funds and large institutions have $276M invested in Aratana Therapeutics, Inc. in 2014 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 44 increasing their positions, 11 reducing their positions, and 18 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 11
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less funds holding
Funds holding: 89 → 82 (-7)
24% less capital invested
Capital invested by funds: $364M → $276M (-$88.3M)
39% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 18
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $5K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$19.5M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$8.77M |
| 3 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$7.99M |
| 4 |
Jennison Associates
New York
|
+$7.74M |
| 5 |
BC
Broadfin Capital
New York
|
+$7.58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$12.3M |
| 2 |
RIM
RS Investment Management
San Francisco,
California
|
-$8.88M |
| 3 |
CIP
Chartwell Investment Partners
Berywn,
Pennsylvania
|
-$6.74M |
| 4 |
FAM
Fred Alger Management
New York
|
-$3.53M |
| 5 |
AP
Alydar Partners
Boston,
Massachusetts
|
-$2.81M |
PETX Hedge Fund Activity: Q3 2014 in Review
82 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Aratana Therapeutics, Inc. (PETX) for Q3 2014, worth a combined $276M — down 24% from $364M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of PETX and 11 opened new positions — a net loss of 7 holders — while 11 trimmed existing stakes and 44 added.
The largest buyer was Wellington Management Group, adding an estimated $19.5M. The largest seller was Deerfield Management, exiting entirely with an estimated $12.3M sold.
- 82 institutional investors held Aratana Therapeutics, Inc. (PETX) as of Q3 2014, down from 89 in Q2 2014.
- Funds reported $276M of Aratana Therapeutics, Inc. stock for Q3 2014, down 24% quarter-over-quarter.
- 11 funds opened new Aratana Therapeutics, Inc. positions in Q3 2014 and 18 closed out, a net change of -7 holders.
- The largest Aratana Therapeutics, Inc. buyer in Q3 2014 was Wellington Management Group, an estimated $19.5M added.
- The largest Aratana Therapeutics, Inc. seller in Q3 2014 was Deerfield Management, an estimated $12.3M sold.
Based on aggregated 13F filings for Q3 2014.